Mylan Launches Offer for Perrigo
September 14 2015 - 9:50AM
Dow Jones News
Mylan NV on Monday officially brought its takeover bid for
Perrigo Co. directly to the company's shareholders, after being
publicly rebuffed since April.
Mylan is offering $75 in cash and 2.3 shares of Mylan for each
Perrigo share held, valued at about $187 based on Friday's closing
price. Perrigo's shares closed at $179.67 a share on Friday, down
8.3% in the past month.
Perrigo shareholders would own about 40% of the combined company
under the terms of the offer, which is set to expire Nov. 13. By
launching the offer, Mylan is bypassing Perrigo's management and
board, which have rebuffed its advances.
The offer is valued at around $27 billion based on Friday's
closing prices, compared with its value of over $35 billion when
Mylan made the latest offer in late April.
Mylan's share price has slid 34% in the past three months.
Mylan in April publicly bid for Perrigo, saying a combination
would create a strong competitor in the quickly consolidating
pharmaceuticals sector. Perrigo has rejected Mylan's offers as too
low.
In late August, Mylan won approval for the bid from two-thirds
of votes cast at its shareholder meeting, and it got support from
more than a majority of the company's shares outstanding.
Mylan also lowered its bar for the deal, saying that rather than
needing support of 80% of Perrigo shares to close the transaction,
a simple majority would suffice.
Mylan and Perrigo are both generic-drug makers, but focus on
different segments of the market. Perrigo makes cold and allergy
medicines and infant formulas, including some sold under chain
brands at Walgreens Boots Alliance Inc. and Wal-Mart Stores
Inc.
Mylan concentrates on generic drugs, but is best known for its
branded EpiPen allergic-reaction treatment, which may soon face
pressure from potential competitors.
Write to Chelsey Dulaney at Chelsey.Dulaney@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
September 14, 2015 09:35 ET (13:35 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024